Health

Healthy Dietary Patterns Linked to Better Life Expectancy

A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary patterns is significantly associated with lower mortality rates and a longer lifespan. Over a median follow-up of 10.6 years, researchers found that five specific diets—the Alternate Healthy Eating Index-2010, Alternate Mediterranean Diet (AMED), healthful Plant-based Diet Index (hPDI), Dietary Approaches to Stop Hypertension (DASH), and Diabetes Risk Reduction Diet (DRRD)—were all linked to reduced all-cause mortality. Notably, individuals in the top quintile of these dietary scores gained between 1.5 to 3.0 years of life at age 45, with the Diabetes Risk Reduction Diet showing the strongest benefit for men and the Mediterranean diet for women. Crucially, these protective effects persisted regardless of genetic susceptibility to other diseases, underscoring that healthy eating can prolong life even without the advantage of longevity genes. Source: https://www.science.org/

hyangiu

Recent Posts

SGLT2 Inhibitors Tied to Lower Risk in Patients with Diabetes and Cirrhosis

A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…

13 hours ago

Lobar and Mixed Cerebral Microbleeds Linked to Increased Dementia Risk

A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…

4 days ago

DASH Diet Best for Long-Term Brain Health

A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…

1 week ago

Intermittent Fasting Shows No Clear Advantage Over Traditional Diets for Weight Loss

A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months…

2 weeks ago

Statin Adverse Effects Analysis: Separating Signal from Noise

To address uncertainties in statin safety profiles, which are often based on observational data susceptible…

3 weeks ago

Early Time-of-Day Immunotherapy Shows Survival Benefit in Lung Cancer Trial

In a Chinese phase 3 trial (LungTIME-C01) involving 210 patients with advanced non-small cell lung…

1 month ago

This website uses cookies.